Overview
- 6 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2023-11-15.
At a glance
Inspections
6
Form 483s
2
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 13 Nov 2023 – 15 Nov 2023 | Human Drugs | Clean | |
| 12 Nov 2019 – 15 Nov 2019 | Human Drugs | 483 | View 483 → |
| 17 Feb 2016 – 19 Feb 2016 | Human Drugs | Clean | |
| 27 Mar 2012 | Not recorded | Clean | |
| 18 Jul 2008 | Not recorded | 483 | On file |
| 7 Apr 2000 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Michael L Casner1 insp.
Arsen Karapetyan1 insp.
Theresa Kirkham1 insp.
German Rivera1 insp.
Marianela Aponte Cruz1 insp.
Daryl A Dewoskin1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.194(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
Full site report
Get the verbatim findings behind Eurofins BioPharma Product Testing Toronto, Inc.'s 2 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat